ANIXA BIOSCIENCES, INC. Operating Leases, Rent Expense
ANIXA BIOSCIENCES, INC. (ANIX) reported Operating Leases, Rent Expense of $16.00 thousand for the 3-month period ending 2020-04-30, per its 10-Q filed 2020-06-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2020-06-09
- ANIXA BIOSCIENCES, INC. operating leases, rent expense for the quarter ending 2020-04-30 was $16.00K, a 33.33% increase year-over-year.
- ANIXA BIOSCIENCES, INC. operating leases, rent expense for the quarter ending 2020-01-31 was $16.00K, a 11.11% decline year-over-year.
- ANIXA BIOSCIENCES, INC. operating leases, rent expense for the quarter ending 2019-04-30 was $12.00K.
- ANIXA BIOSCIENCES, INC. operating leases, rent expense for the quarter ending 2019-01-31 was $18.00K.
- ANIXA BIOSCIENCES, INC. operating leases, rent expense for fiscal 2019 was $60.00K, a 47.37% decline from fiscal 2018.
- ANIXA BIOSCIENCES, INC. operating leases, rent expense for fiscal 2018 was $114.00K, a 50.22% decline from fiscal 2017.
- ANIXA BIOSCIENCES, INC. operating leases, rent expense for fiscal 2017 was $229.00K, a 21.81% increase from fiscal 2016.
- ANIXA BIOSCIENCES, INC. operating leases, rent expense for fiscal 2016 was $188.00K, a 88.00% increase from fiscal 2015.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|---|
| 2020-04-30 | $16.00K 10-Q · filed 2020-06-09 | $32.00K 10-Q · filed 2020-06-09 | ||
| 2020-01-31 | $16.00K 10-Q · filed 2020-03-09 | |||
| 2019-10-31 | $60.00K 10-K · filed 2020-01-09 | |||
| 2019-04-30 | $12.00K 10-Q · filed 2020-06-09 | $30.00K 10-Q · filed 2020-06-09 | ||
| 2019-01-31 | $18.00K 10-Q · filed 2020-03-09 | |||
| 2018-10-31 | $114.00K 10-K · filed 2020-01-09 | |||
| 2017-10-31 | $229.00K 10-K · filed 2019-01-11 | |||
| 2016-10-31 | $188.00K 10-K · filed 2018-01-09 | $104.00K 10-K · filed 2016-12-08 | ||
| 2015-10-31 | $100.00K 10-K · filed 2015-12-23 | |||
| 2014-10-31 | $109.00K 10-K · filed 2015-12-23 | |||
| 2013-10-31 | $360.00K 10-K · filed 2015-01-29 | |||
| 2012-10-31 | $305.00K 10-K/A · filed 2014-01-17 | |||
| 2011-10-31 | $307.00K 10-K · filed 2013-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |